Corcept Therapeutics Shares Outstanding 2006-2019 | CORT

Corcept Therapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 127
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
2008 47
2007 34
2006 23
2005 23
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 124
Q4 2018 127
Q3 2018 126
Q2 2018 128
Q1 2018 128
Q4 2017 125
Q3 2017 126
Q2 2017 123
Q1 2017 121
Q4 2016 116
Q3 2016 116
Q2 2016 115
Q1 2016 110
Q4 2015 107
Q3 2015 108
Q2 2015 108
Q1 2015 102
Q4 2014 101
Q3 2014 101
Q2 2014 101
Q1 2014 101
Q4 2013 100
Q3 2013 100
Q2 2013 100
Q1 2013 100
Q4 2012 93
Q3 2012 99
Q2 2012 89
Q1 2012 84
Q4 2011 83
Q3 2011 84
Q2 2011 84
Q1 2011 81
Q4 2010 68
Q3 2010 72
Q2 2010 66
Q1 2010 63
Q4 2009 52
Q3 2009 50
Q2 2009 50
Q1 2009 50
Q4 2008 47
Q3 2008 49
Q2 2008 48
Q1 2008 40
Q4 2007 34
Q3 2007 37
Q2 2007 35
Q1 2007 26
Q4 2006 23
Q3 2006 23
Q2 2006 23
Q1 2006 23
Q4 2005 23
Q3 2005 23
Q2 2005 23
Q1 2005 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.231B $0.251B
Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.318B 34.70
Astellas Pharma (ALPMY) Japan $28.136B 13.80
Takeda Pharmaceutical (TAK) Japan $27.904B 8.19
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.830B 27.22
Grifols, S.A (GRFS) Spain $15.051B 19.03
Merck (MKGAF) Germany $13.273B 18.11
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.487B 20.74
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Sage Therapeutics (SAGE) United States $9.220B 0.00
Neurocrine Biosciences (NBIX) United States $7.950B 0.00
Catalent (CTLT) United States $7.831B 31.43
Jazz Pharmaceuticals (JAZZ) Ireland $7.737B 10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.663B 9.23
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.786B 16.82
Tilray (TLRY) Canada $4.318B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $4.003B 0.00
United Therapeutics (UTHR) United States $3.326B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.177B 11.40
Arrowhead Pharmaceuticals (ARWR) United States $2.670B 402.29
Xencor (XNCR) United States $2.517B 68.71
PTC Therapeutics (PTCT) United States $2.512B 0.00
Zogenix (ZGNX) United States $2.004B 0.00
Portola Pharmaceuticals (PTLA) United States $1.749B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.689B 81.82
Ironwood Pharmaceuticals (IRWD) United States $1.614B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.604B 21.92
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.482B 0.00
USANA Health Sciences (USNA) United States $1.446B 12.57
ArQule (ARQL) United States $1.164B 0.00
Aerie Pharmaceuticals (AERI) United States $1.119B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.014B 0.00
Radius Health (RDUS) United States $1.010B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.977B 3.52
Spectrum Pharmaceuticals (SPPI) United States $0.880B 0.00
Endo (ENDP) Ireland $0.835B 1.34
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.652B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.594B 0.00
TherapeuticsMD (TXMD) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Organogenesis Holdings (ORGO) United States $0.576B 0.00
GlycoMimetics (GLYC) United States $0.549B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.481B 0.00
ChemoCentryx (CCXI) United States $0.480B 0.00
Akebia Therapeutics (AKBA) United States $0.477B 0.00
Dermira (DERM) United States $0.465B 0.00
Siga Technologies (SIGA) United States $0.461B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.12
Dova Pharmaceuticals (DOVA) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.418B 0.00
CV Sciences (CVSI) United States $0.417B 0.00
Flexion Therapeutics (FLXN) United States $0.415B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.409B 0.00
Indivior (INVVY) United States $0.401B 1.45
BioCryst Pharmaceuticals (BCRX) United States $0.393B 0.00
CannTrust Holdings (CTST) Canada $0.388B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
ImmunoGen (IMGN) United States $0.341B 0.00
Xeris Pharmaceuticals (XERS) United States $0.333B 0.00
KalVista Pharmaceuticals (KALV) United States $0.297B 0.00
OptiNose (OPTN) United States $0.291B 0.00
Rafael Holdings (RFL) United States $0.287B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.263B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.243B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
Lannett Co Inc (LCI) United States $0.227B 2.20
Ocular Therapeutix (OCUL) United States $0.222B 0.00
Recro Pharma (REPH) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.220B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.215B 0.00
Redhill Biopharma (RDHL) Israel $0.184B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 55.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.168B 0.00
IMV INC (IMV) Canada $0.166B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.142B 0.00
Majesco Entertainment (PTE) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.124B 0.00
AgeX Therapeutics (AGE) United States $0.120B 0.00
DURECT (DRRX) United States $0.112B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
Aclaris Therapeutics (ACRS) United States $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.33
Avadel Pharmaceuticals (AVDL) Ireland $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Cardiome Pharma (CORV) Canada $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.23
China SXT Pharmaceuticals (SXTC) China $0.080B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.080B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.076B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.061B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00